Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection

Table 5 Studies reporting eradication rates and cumulative effect of different therapeutic strategies

% Eradication rate (number of patients)
	First-line	Second-line	Third-line	Cumulative effect (II to III line)	Antimicrobial susceptibility testing before third-line
Gasbarrini et al[41] 2000	86 (2413)	82 (329)	77 (39)	99	Yes
Beales[42] 2001	73 (469)	70-73 (66)	65 (20)	94-98	Yes
Qasim et al[40] 2005	77 (3280)	56 (270)	38 (28)
Gisbert et al[32] 2008	70 (500)	74 (343)	76 (136)	99.5	No
Rokkas et al[28] 2009	76 (540)	73 (120)	70 (30)	98	No
Present study	75 (2428)12	85 (326)	89 (19)	97.8-99.9	No

¹172 and 23 patients were found to be affected respectively by duodenal and gastric ulcer. 7 patients were affected by both gastric and duodenal ulcer;

²1 patient was affected by low-grade mucosa-associated lymphoid tissue. Among the patients with a history of previous gastric surgery, 1 patient had undergone surgery for cancer, the others for peptic ulcer disease. UBT: Urea breath test.